Mitochondrial dysfunction, a hallmark of MASLD/MASH, can result in the accumulation of mtDNA, which in turn triggers the activation of the cGAS-STING pathway (98). Here, STING1 is linked to metabolic dysfunction-associated steatotic liver disease.